MEGAN GUINAN: Open Payments
NPI 1326480104 · PHOENIXVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 31 payments from 20 companies in 2025. Trend: 2023 $83 · 2024 $778 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Daiichi Sankyo Inc. | 2 | $53 |
| Alexion Pharmaceuticals, Inc. | 2 | $53 |
| Stemline Therapeutics Inc. | 2 | $53 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| GENZYME CORPORATION | 2 | $44 |
| Pharmacosmos Therapeutics Inc. | 1 | $31 |
| Exelixis Inc. | 1 | $30 |
Products named: ENHERTU, TALVEY, ULTOMIRIS, Orserdu, SARCLISA, KEYTRUDA, MONOFERRIC, KISQALI.
Industry payments across PA — which companies pay providers there.
